序号 专利名 申请号 申请日 公开(公告)号 公开(公告)日 发明人
21 Pesticidal compounds US891079 1997-07-10 US6043286A 2000-03-28 Bhupinder Pall Singh Khambay; Duncan Batty
Pesticidal as a pesticide against whitefly, Lepidoptera and certain fungi is provided of compound of general formula (I) ##STR1## or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1;each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alkyl, alkenyl, haloalkyl, haloalkenyl, alkoxy, haloalkoxy, haloalkenoxy, amino, alkylamino, dialkylamino, alkoxycarbonyl, carboxyl, alkanoyl, alkylthio, alkylsulphinyl, alkylsulphonyl, carbamoyl, alkylamido, cycloalkyl, aryl or aralkyl group;R.sup.1 and R.sup.2 each independently represent an optionally substituted alkoxy group or together represent a group .dbd.O, .dbd.S or .dbd.N--OR.sup.9, where R.sup.9 represents a hydrogen atom or an optionally substituted alkyl group;R.sup.3 represents a hydroxyl group, or a group --OL where L is a leaving group, or a group which in vivo is transformed into a group --OL.sup.1 where L.sup.1 is a leaving group;R.sup.7 and R.sup.8 independently represent an optionally substituted alkoxy group or together represent a group .dbd.O, .dbd.S or .dbd.N--OR.sup.9, where R.sup.9 is as previously defined;wherein R.sub.4 and R.sub.5 independently represent a halogen atom or an optionally substituted alkyl or alkenyl group, or together with the interjacent carbon atom represent an optionally substituted cycloalkyl or cycloalkenyl ring; andA represents a straight or branched chain alkyl or alkenyl group, which may be optionally substituted, an acyclic carbon chain of which links the 3 position of the naphthalene ring shown and the moiety --CHR.sup.4 R.sup.5 and wherein A does not include a quaternary carbon atom in that chain; andwherein the total number of carbon atoms in the longest carbon chain running from the 3-position of the naphthalene ring shown is no more than 8.
22 Tertiary non-linear optical material US307707 1995-01-26 US5679808A 1997-10-21 Akira Mizoguchi; Yasuhiro Hattori; Michiru Kubata
The present invention discloses a tertiary non-linear optical material comprising a quinone derivative expressed by any one of the general formulas: ##STR1## wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and R.sup.6 are as defined above, or the formula: ##STR2## The tertiary non-linear material enables the co-existence of large tertiary non-linear optical susceptibility and high-speed response.
23 Octahydrotetracyanoquinodimethane and derivatives thereof US386790 1982-06-08 US4510089A 1985-04-09 Shu Hotta; Tomiharu Hosaka; Wataru Shimotsuma
1,2,3,4,5,6,7,8-Octahydro-11,11,12,12-tetracyano-9,10-anthraquinodimethane compounds of the general formula ##STR1## in which W, X, Y and Z independently represent hydrogen, halogen, hydroxyl group, hydrocarbon group having 1 to 8 carbon atoms, alkoxy group or acyloxy group provided that W=Y and X=Z, or W=Z and X=Y. The compositions and charge transfer complexes comprising these compounds are also described together with intermediates for the compounds.
24 Quinone compounds, their production and use US511083 1983-07-05 US4489096A 1984-12-18 Shinji Terao; Yoshitaka Maki
New quinone compounds of the formula: ##STR1## wherein R is methyl or methoxy andY is formyl, carboxyl, an alkoxycarbonyl having 2 to 5 carbon atoms, carbamoyl, a mono- or di- alkylcarbamoyl whose alkyl moiety has 1 to 4 carbon atoms or carbamoyloxymethyl, ortheir hydroquinone-form compounds, or pharmaceutically acceptable salts thereof, have useful physiological activities such as antiasthmatic and antiallergic activities.
25 NEW COMPOUNDS OF THE PTEROCARPANQUINONE FAMILY, METHOD FOR PREPARING THE SAME, PHARMACEUTICAL COMPOSITION CONTAINING THE NEW COMPOUNDS OF THE PTEROCARPANQUINONE FAMILY, USES AND THERAPEUTIC METHOD EP09825667.0 2009-11-05 EP2366684A1 2011-09-21 DA SILVA, Alcides José Monteiro; RUMJANEK, Vivian Mary Barral Dold; BERGMANN, Bartira Rossi; DOS SANTOS, Eduardo Salustiano Jesus; COSTA, Paulo Roberto, Ribeiro; NETTO, Chaquip Daher; LIMA, Wallace, Pacienza; DOS SANTOS, Eduardo Caio Torres; CAVALCANTE, Moisés Clemente, Marinho; SEABRA, Sérgio, Henrique; RICA, Sérgio Henrique

This invention belongs to the chemical-pharmaceutical field. New compounds of pterocarpanquinone family presented in formula (I) according to this invention are capable to be activated by reduction generating alkylating species intracellularly. It presents selective cytotoxic effects particularly on mammalian human and nonhuman cells that divide constantly and are useful in treating diseases and dysfunctions related to the phenomenon of undesired cell proliferation. Such compounds are also effective for the treatment of diseases or dysfunctions related to high levels of TNF-α in human and nonhuman mammals.

26 BLENDS OF QUINONE ALKIDE AND NITROXYL COMPOUNDS AS POLYMERIZATION INHIBITORS EP01981357.5 2001-10-02 EP1332196A1 2003-08-06 BENAGE, Brigitte
Disclosed herein is a method for inhibiting the premature polymerization of ethylenically unsaturated monomers comprising adding to said monomers an effective amount of: A) at least one nitroxyl compound, and B) at least one quinone alkide compound having an electron-withdrawing group at the 7-position. Additionally, a composition is disclosed that comprises: A) at least one nitroxyl compound, and B) at least one quinone alkide compound having an electron-withdrawing group at the 7-position.
27 ORGANIC CONDUCTIVE COMPLEX ORGANIC CONDUCTIVE COMPLEX EP89111686 1989-06-27 EP0350709A3 1990-08-22 MATSUOKA, MASARU; KITAO, TEIJIRO; SHIMIZU, YO C/O OSAKA WORKS OF
28 Organic conductive complex EP89111686.5 1989-06-27 EP0350709A2 1990-01-17 Matsuoka, Masaru; Kitao, Teijiro; Shimizu, Yo c/o Osaka Works of

An organic conductive complex comprising an electron donor and an electron acceptor, the electron donor being an anthraquinone derivative represented by formula (1): wherein X¹, X², X³ and X⁴, which may be the same or different, each represents an electron donating group.

29 Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array US15050377 2016-02-22 US10006131B1 2018-06-26 Karl Maurer; John J. Cooper, Jr.
There is disclosed an electrochemical deblocking solution for use on an electrode microarray. There is further disclosed a method for electrochemical synthesis on an electrode array using the electrochemical deblocking solution. The solution and method are for removing acid-labile protecting groups for synthesis of oligonucleotides, peptides, small molecules, or polymers on a microarray of electrodes while substantially improving isolation of deblocking to active electrodes. The method comprises applying a voltage or a current to at least one electrode of an array of electrodes. The array of electrodes is covered by the electrochemical deblocking solution.
30 PHOTODYNAMIC DIAGNOSIS, FORMULATIONS USABLE AS PHOTOSENSITIZERS FOR THIS PURPOSE, METHOD FOR THE PRODUCTION AND USE THEREOF US15469602 2017-03-27 US20170196976A1 2017-07-13 Stefan WELZIG; Beate KÄLZ; József GUNGL; Klaus GERDES; Werner FRANTSITS; Christina ABRAHAMSBERG
In the early detection of cancer, in particular bladder cancer, a photodynamic diagnosis uses, as a photosensitizer, a formulation that contains sodium hypericinate that is bonded to polyvinylpyrrolidone or complexed with polyvinylpyrrolidone.
31 UV stable microbial insecticides, methods of making, methods of using US803670 1997-02-21 US5998330A 1999-12-07 Gary W. Felton
A method of treating vegetation by application of a microbial insecticide in which a quinone has been covalently bonded to the viral occlusion body surface of the microbial insecticide in order to improve the UV stability of the microbial insecticide by forming a protective shield around the pathogen.
32 Preparation process of naphthoquinone derivative and intermediate for the preparation thereof US280550 1994-07-26 US5412124A 1995-05-02 Kimio Hamamura; Chiaki Seki; Masayuki Konishi
Disclosed herein are a naphthoquinone derivative represented by the following formula: ##STR1## wherein R.sup.1 means a hydrogen atom or methyl group, R.sup.2 is a hydrogen atom or methyl group, n stands for 0 or an integer of 1-9, and a linkage is a single bond or double bond with the proviso that if n is an integer of 2-9, the linkages may be identical with or different optionally from each other, such as a vitamin K derivative; and a process for producing the naphthoquinone derivative at a high yield without forming any geometric isomer; as well as 1,4,4.sub.a,5,8,9.sub.a -hexahydro-4.sub.a .alpha.-alkenyl-1.alpha.,4.alpha.-methanoanthraquinone derivatives and 1,4,4.sub.a,5,8,9.sub.a -hexahydro-1.alpha.,4.alpha.-methanoanthraquinone derivatives which are useful as intermediates for the preparation of the naphthoquinone derivatives.
33 Light-stable reducible compounds and analytical compositions, elements and methods utilizing same US868479 1986-05-30 US4797357A 1989-01-10 Albert J. Mura; Paul B. Merkel
Certain reducible aromatic and quinone compounds having bulky groups on the carbamate nitrogen atom have improved stability to light. These compounds are useful in analytical compositions, elements and methods, e.g. for assays of bacterial cells. These compounds have suitable substituents that promote the release of phenalenone or benzphenalenone fluorescent dyes at physiological pH.
34 Polymerization inhibitors US664282 1984-10-24 US4590301A 1986-05-20 Drahoslav Lim; Peter C. Morris
Compounds of the general formula ##STR1## wherein n, R.sub.1, R.sub.2 and X are defined herein, are effective inhibitors of polymerization of vinylic monomers, particularly acrylic monomers. The inhibitors are easily, efficiently, and thoroughly removed from solution with the monomer by contact with charcoal.
35 Complex salts having high electric conductivity US408668 1982-08-16 US4478751A 1984-10-23 Friedrich Jonas; Jurgen Hocker; Bruno Broich
Complex salts of 7,7,8,8-tetracyano-p-quinodimethane having high electric conductivity, process for the preparation thereof and the use thereof as electric conductors, semiconductors or photoconductors and for antistatic finishing of plastics products.
36 Naphthoquinone anti-psoriatic agents US459165 1983-01-19 US4442127A 1984-04-10 Gordon H. Jones; John M. Young
Psoriasis in mammals is relieved by topically administering naphthoquinones of the formula: ##STR1## wherein: R.sup.1 and R.sup.2 are lower alkoxy; andR.sup.3 is halo or cyano.
37 Purification of naphthoquinone US22878 1979-03-22 US4257851A 1981-03-24 Ryo Matsuura; Kazuaki Sakai; Tuneyasu Sato; Yorinobu Yamada; Kowzo Bandow
A crude naphthoquinone produced by an oxidation of naphthalene is purified by a reduced pressure distillation of a crude 1,4-naphthoquinone having an acid content of less than 5 equivalent % calculated as monobasic acid and the crude naphthoquinone is preferably treated by an oxidation of oxidizable impurities.
38 Polyarylene copolymer having an aromatic compound and a sulfonic acid group, and their use JP2008551153 2007-12-27 JP5597924B2 2014-10-01 敏明 門田; 芳孝 山川
39 Treatment for making pitch fiber infusible JP31028595 1995-11-29 JPH09143822A 1997-06-03 OTA ETSURO
PROBLEM TO BE SOLVED: To provide a treating method for making a pitch fiber infusible, capable of markedly reducing a time required for the treatment under an oxidizing atmosphere by adding quinones to a carbonaceous pitch and melt spinning. SOLUTION: This treating method for making a pitch fiber infusible, is to add 0.01-50wt.% quinones such as pyrenequinone and phenanthrene to a carbonaceous pitch capable of melt spinning, and melt spin it. It is possible to improve a productivity by reducing the time required for the following treatment for making the fiber infusible without adding any specific process. COPYRIGHT: (C)1997,JPO
40 Production of quinones JP31814994 1994-12-21 JPH08176059A 1996-07-09 SAKAMOTO TAKAAKI; YONEHARA YOSHITOMO; BOKU SHIYOUSHIN
PURPOSE: To produce a quinone compound useful as a polymerization inhibitor, an unsaturated polyester stabilizer, intermediate for pharmaceuticals and agrochemicals, etc., in an easily separable state without causing a side reaction by oxidizing a hydroquinone compound in the presence of a small amount of a supported copper salt while repeatedly using the supported copper salt. CONSTITUTION: This quinone compound is produced by oxidizing (A) a hydroquinone compound with an oxygen-containing gas e.g. in an organic solvent in the presence of (B) a supported copper salt obtained e.g. by adding a bivalent copper salt (e.g. cupric sulfate, cupric halide or cupric acetate) and a carrier such as an inorganic carrier (e.g. alumina, silica gel or florisil) to a polar solvent capable of dissolving the copper salt (e.g. water or alcohol) and removing the solvent from the solution e.g. by evaporation. The amount of the component B is preferably 0.005-1.0 equivalent in terms of the copper salt based on 1 equivalent of the component A and the oxidation reaction is carried out preferably at 40-300°C. COPYRIGHT: (C)1996,JPO
QQ群二维码
意见反馈